Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing asparaginase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
L-asparaginase |
Inferred relationship |
Some |
|
Crisantaspase poisoning (disorder) |
Causative agent |
False |
L-asparaginase |
Inferred relationship |
Some |
|
Accidental crisantaspase poisoning |
Causative agent |
False |
L-asparaginase |
Inferred relationship |
Some |
|
Intentional crisantaspase poisoning |
Causative agent |
False |
L-asparaginase |
Inferred relationship |
Some |
|
forgiftning med crisantaspase, uvist med hvilken hensigt |
Causative agent |
False |
L-asparaginase |
Inferred relationship |
Some |
|
Crisantaspase adverse reaction |
Causative agent |
False |
L-asparaginase |
Inferred relationship |
Some |
|
Allergy to crisantaspase (finding) |
Causative agent |
False |
L-asparaginase |
Inferred relationship |
Some |
|
crisantaspase 10.000 IE pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
L-asparaginase |
Inferred relationship |
Some |
|
Product containing crisantaspase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
L-asparaginase |
Inferred relationship |
Some |
|
L-asparaginase 10.000 IE pulver til injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
L-asparaginase |
Inferred relationship |
Some |
|
Product containing pegaspargase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
L-asparaginase |
Inferred relationship |
Some |
|
pegaspargase 750 IE/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
L-asparaginase |
Inferred relationship |
Some |
|
Accidental crisantaspase poisoning |
Causative agent |
False |
L-asparaginase |
Inferred relationship |
Some |
|
Intentional crisantaspase poisoning |
Causative agent |
False |
L-asparaginase |
Inferred relationship |
Some |
|